The follow-on or copycat insulin glargine product Basaglar (Lilly) is similar to brand-name Lantus (Sanofi) in terms of efficacy and safety for the treatment of type 2 diabetes, but Basaglar cost less ...
Original Medicare (parts A and B) typically doesn’t cover Basaglar, an insulin glargine medication, but Medicare Advantage (Part C) and Part D plans may offer coverage depending on their specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results